InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Skaff Michael C. Director active across 1 company, notably Vivos Therapeutics, Inc.. Cumulatively, 2 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €1.6m. Activity tracked since 31 March 2026. The latest transaction was filed on 31 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations